ABSTRACT
We tested the capacity of the Sysmex UF-1000i system to detect yeasts in urine by screening a total of 22 132 urine samples received for culture in our microbiology laboratory during 1 year. We also analyzed different dilutions of previously filtered urine inoculated with a strain of Candida albicans. With clinical samples, a single cut-off point of 50 yeast-like cells (YLCs)/µL detected candiduria ≥10 000 colony forming units (CFU)/mL and >100 000 CFU/mL with a sensitivity of 87.3%/95.4%, a specificity of 97%, a negative predictive value of 95.9%, and a positive predictive value of 9.3%/5.7%. With the simulated samples, a linear relationship was observed between the dilution factor and the number of cells detected by UF-1000i. This instrument appears to be able to reliably rule out candiduria of a magnitude of at least 10 000 CFU/mL and facilitate urine sample screening, thereby providing fast results. The Sysmex UF1000i system can be adapted for candiduria screening by the use of an appropriate YLCs/µL cut-off point that takes account of the prevalence of candiduria in the population.
Subject(s)
Mycology/methods , Urinary Tract Infections/diagnosis , Urinary Tract Infections/microbiology , Urine/microbiology , Yeasts/isolation & purification , Adult , Aged , Automation, Laboratory , Candidiasis/diagnosis , Candidiasis/microbiology , Colony Count, Microbial/methods , Colony Count, Microbial/statistics & numerical data , Female , Humans , Infant , Male , Mycology/statistics & numerical data , Mycoses/diagnosis , Mycoses/microbiology , PregnancyABSTRACT
INTRODUCTION: Female immigration from less developed countries into Spain has grown in number over the years, and could contribute to changing the prevalence of routine serological markers in pregnant women. MATERIAL AND METHODS: From April 2007 until May 2008 we studied the prevalence of serum antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, human immunodeficiency virus (HIV 1/2), and hepatitis B virus (HBV) in samples from 4,171 immigrant and Spanish pregnant women in Granada. RESULTS: The seroprevalence of toxoplasmosis in pregnant immigrants was higher than in non-immigrants (44% vs. 14.4%). The overall prevalence against rubella was 97.3%. Sub-Saharan and North African women showed the lowest prevalence (88% and 89%). The prevalence of HBsAg was higher in immigrants than in Spanish women (2.6% vs. 0.4%), and especially high among the Eastern European (6.9%) and Asian (8.1%) pregnant women. The seroprevalences of HIV (0.9% vs. 0.1%) and syphilis (TPHA) (3.5% vs. 0.07%), were higher in immigrants. Seroprevalence against T. pallidum was higher among Eastern European (11.5%) and Latin-American (3.5%) women, whereas sub-Saharan (11.8%) and North African (1%) women showed the highest anti-HIV prevalence. CONCLUSION: Hepatitis B, anti-HIV, syphilis, and antibodies against T. gondii are found more frequently in immigrants than in Spanish pregnant women, whereas rubella protection in Spanish women is higher than immigrant pregnant women.
Subject(s)
Emigrants and Immigrants/statistics & numerical data , Pregnancy Complications, Infectious/epidemiology , Africa/ethnology , Antibodies, Bacterial/blood , Antibodies, Protozoan/blood , Antibodies, Viral/blood , Asia/ethnology , Cross-Sectional Studies , Europe, Eastern/ethnology , Female , HIV Infections/epidemiology , HIV Infections/ethnology , HIV Seroprevalence , Hepatitis B/epidemiology , Hepatitis B/ethnology , Humans , Latin America/ethnology , Pregnancy , Pregnancy Complications, Infectious/ethnology , Prevalence , Rubella/epidemiology , Rubella/ethnology , Seroepidemiologic Studies , Spain/epidemiology , Syphilis/epidemiology , Syphilis/ethnology , Toxoplasmosis/epidemiology , Toxoplasmosis/ethnologyABSTRACT
A new member of the phlebovirus genus, tentatively named Granada virus, was detected in sandflies collected in Spain. By showing the presence of specific neutralizing antibodies in human serum collected in Granada, we show that Granada virus infects humans. The analysis of the complete genome of Granada virus revealed that this agent is likely to be a natural reassortant of the recently described Massilia virus (donor of the long and short segments) with a yet unidentified phlebovirus (donor of the medium segment).
Subject(s)
Phlebotomus Fever/virology , Psychodidae/virology , Sandfly fever Naples virus/classification , Sandfly fever Naples virus/genetics , Animals , Antibodies, Viral/blood , Base Sequence , Chlorocebus aethiops , Female , Genome, Viral , Humans , Insect Vectors/virology , Male , Molecular Sequence Data , Phlebotomus Fever/epidemiology , Phylogeny , Reassortant Viruses , Sandfly fever Naples virus/immunology , Seroepidemiologic Studies , Vero CellsABSTRACT
Osteonecrosis of the jaw associated to biphosphonate use is more common in cancer patients with bone metastases, that are using intravenous diphosphonates. When these drugs are used orally the risk of the complication is lower. We report 3 diabetic women aged 69, 76 and 82 years, receiving alendronate 70 mg every one week. The unveiling event was the extraction of several teeth without the use of antibiotics. All had bone pain, purulent discharge, loss of bone and halitosis. All improved five months after discontinuing alendronate.
Subject(s)
Alendronate/adverse effects , Bone Density Conservation Agents/adverse effects , Jaw Diseases/chemically induced , Osteonecrosis/chemically induced , Aged , Aged, 80 and over , Diabetes Mellitus, Type 2/drug therapy , Female , Humans , Maxillary Diseases/chemically inducedABSTRACT
Osteonecrosis of the jaw associated to biphosphonate use is more common in cancer patients with bone metastases, that are using intravenous diphosphonates. When these drugs are used orally the risk of the complication is lower. We report 3 diabetic women aged 69, 76 and 82 years, receiving alendronate 70 mg every one week. The unveiling event was the extraction of several teeth without the use of antibiotics. All had bone pain, purulent discharge, loss of bone and halitosis. All improved five months after discontinuing alendronate.